The blockchain tool will be used in oncology clinical research and development. Patients will be able to access their data through the decentralized ledger. New York-based Embleema’s blockchain will also give clinical researchers the opportunity to monitor the safety and effectiveness of new investigational drugs.
Through the blockchain platform, patients can receive digital tokens for participating in clinical studies. The patient-focused blockchain allows users to sign smart contracts, giving anonymity to patient data. Patients can access the blockchain and alter their contracts at any time.
Patients can also share real-time healthcare data with various life science companies to improve the timeline for new drug development.
To read the full report, click here.
More articles on health IT:
Alabama health system transitions to Cerner EHR: 3 things to know
JPM cryptocoin ‘great for blockchain,’ but lacks interoperability, Ripple CEO says
Philips to acquire Carestream Health IT business: 3 notes
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.